CPIC

Search results for: “14”

  • 2014 Conference Call Minutes

    ACMG standards_CYP2D6 CPIC call Oct 2014 CPIC possible gene_drug pairs_2015-2020 mvr minutes cpic Dec 2014 minutes cpic february 2014 minutes cpic july 2014 minutes cpic june 2014 minutes cpic March 2014 minutes cpic may 2014 minutes cpic Nov 2014 minutes cpic Oct 2014 minutes cpic Sept 2014 PROPOSED Local Coverage Determination 2C19 2D6 2C9 VKORC1

  • ClinPGx 2024 – Accommodations

    HOTEL(S) OFFERING SPECIAL GROUP RATE Cutoff date for reservations is Monday, May 20, 2024 Sheraton Philadelphia University City Hotel3549 Chestnut Street, Philadelphia, PA 19104To make reservations:Call: 888-627-7071Booking WebsiteParking at the hotel is $39 (+tax). The Inn at Penn, A Hilton Hotel3600 Samson Street, Philadelphia, PA 19104To make reservations:Booking Website

  • CPIC® guideline for statins and SLCO1B1, ABCG2, and CYP2C9

    Most recent guideline publication: The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms (January 2022) Updates since publication: none Tables provided in the main manuscript of the guideline: Table 1. Assignment of predicted SLCO1B1, ABCG2, and CYP2C9 likely phenotype based on genotype Table 2. Dosing recommendations for statins…

  • CPIC® Guideline for G6PD

    Guideline overview presentation Most recent guideline publication: Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype (August 2022) Tables  provided in the main manuscript of the guideline: Table 1. Assignment of predicted G6PD phenotype based on genotype Table 2. Drug-specific risk level and associated strength of recommendation for…

  • CPIC Communication

    There are a few different ways to stay in touch with CPIC. I have a question or comments Contact us with any questions or comments. I have a question or comment about allele function or diplotype-phenotype tables Contact us with questions specifically about CPIC alleles I want to get announcements CPIC has a public announcement…

  • PGx Dissemination Working Group

    Goal and Focus A formal working group within CPIC, PharmGKB, PharmVar, and the PGRN was formed in 2018 to focus on the dissemination of resources available for pharmacogenetic implementation such as CPIC guidelines, PharmGKB, PGRN and PharmVar resources, and implementation strategies of pharmacogenetics. The goal of the CPIC Dissemination Working Group is to support the…

  • CPIC® Guideline for Potent Volatile Anesthetic Agents and Succinylcholine and RYR1 and CACNA1S

    Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes Updates since publication: December 2023: Subsequent to the publication of the CPIC guideline for RYR1 and malignant hyperthermia (PMID 30499100), the ClinGen variant curation expert panel (VCEP) developed and published…

  • CPIC® Guideline for Phenytoin and CYP2C9 and HLA-B

    Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C9 and HLA-B Genotype and Phenytoin Dosing (August 2020) Updates since publication: No updates on dosing recommendations since publication. Tables and figure provided in the main manuscript of the guideline: Table 1. Assignment of likely HLA-B phenotypes based on genotypes Table 2. Assignment of…

  • CPIC® Guideline for Tacrolimus and CYP3A5

    Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 genotype and Tacrolimus Dosing (July 2015) Updates since publication: No updates on dosing recommendations since publication. Tables provided in the main manuscript of the guideline: Table 1. Assignment of likely metabolism phenotypes based on CYP3A5 diplotypes Table 2. Dosing recommendations for tacrolimus based…

  • CPIC® Guideline for PEG Interferon-Alpha-Based Regimens and IFNL3

    Most recent guideline publication: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for IFNL3 (IL28B) Genotype and PEG interferon-alpha-based Regimens (February 2014) Updates since publication: No updates on dosing recommendations since publication. Tables provided in the main manuscript of the guideline: Table 1 Assignment of probable IFNL3 phenotypes based on genotypes Table 2 Recommendations for use of…